Company Directory / research

PrivateFor profitresearchMontreal, Canada
Congruence Therapeutics operates as a biotechnology company.
Size
11-50 people: larger than 33% of companies with a size listed
Age
5 years old.
Reach
Website ranked #13,274,660 in the world for traffic, about 78 visits a month.
BiotechnologyMedical
Funding, as listed
$65M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Congruence Therapeutics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Congruence Therapeutics may be growing as it is highlighted among Montreal biotech companies to keep an eye on, suggesting a recognition of its potential in the biotech industry. The company's foundation two years ago and its inclusion in discussions about the growth of Canada's biotech sector indicate recent establishment and relevance in a growing industry. Furthermore, the leadership by the former CEO of Clementia, who now leads Congruence Therapeutics, implies experienced management which could contribute to the company's growth trajectory.
Summaries written by the source dataset, not by us, and not checked.
research in Canada.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 136,547 companies in Canada and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.